A US cohort study suggested that metformin cessation was associated with increased dementia incidence. The cohort consisted of 12 220 early terminators and 29 126 routine users, respectively (women 46.2% and 46.6%, respectively; mean age at start of first metformin prescription 59.4 and 61.1 years, respectively). Early terminators had 1.21 times the hazard of dementia diagnosis compared with routine users (hazard ratio, 1.21). Mediation analysis indicated that the association was not mediated by insulin use 1 or 5 years after metformin cessation, and minimally mediated by HbA1c level at 1 year after metformin cessation, suggesting that the association was largely independent of changes in HbA1c level and insulin usage. The findings are in line with other observational studies showing an association between metformin use and lower dementia incidence, with potential implications for diabetes treatment in late life. Source: https://jamanetwork.com/
A secondary MRI analysis of the US POINTER randomized clinical trial found that a structured…
Dementia risk factors vary substantially across countries, but they frequently cluster together in similar patterns…
A systematic review and network meta-analysis of 262 randomized trials involving 99,791 participants found that…
Approximately 21% of patients with phenotypically mild hypertrophic cardiomyopathy (HCM) experienced major adverse cardiovascular events…
A Danish randomized crossover trial found that a single session of high-intensity interval exercise (HIIE)…
Baseline use of proton pump inhibitors (PPIs) and, to a lesser extent, antibiotics was associated…
This website uses cookies.